IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction - A comparative study of human clinical-applicable DC

Clinical Immunology

Volumn 142, Issue 3, 2012, Pages 332-342

  Boks, Martine A ^a   Kager Groenland, Judith R ^a   Haasjes, Michiel S P ^a   Zwaginga, Jaap Jan ^a,b   van Ham, S Marieke ^a   ten Brinke, Anja ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CGMP; Migration; Regulatory t cells; Stability; Suppression; Tolerance induction

Indexed keywords

COLECALCIFEROL; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; CELL MATURATION; CELL MIGRATION; CELL THERAPY; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL21; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84857370127     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.11.011     Document Type: Article

References (64)

1. Horibe E.K., Sacks J., Unadkat J., Raimondi G., Wang Z., Ikeguchi R., Marsteller D., Ferreira L.M., Thomson A.W., Lee W.P., Feili-Hariri M. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl. Immunol. 2008, 18:307-318.
2. Raimondi G., Sumpter T.L., Matta B.M., Pillai M., Corbitt N., Vodovotz Y., Wang Z., Thomson A.W. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J. Immunol. 2010, 184:624-636.
3. Bonham C.A., Peng L., Liang X., Chen Z., Wang L., Ma L., Hackstein H., Robbins P.D., Thomson A.W., Fung J.J., Qian S., Lu L. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol. 2002, 169:3382-3391.
4. van Duivenvoorde L.M., Han W.G., Bakker A.M., Louis-Plence P., Charbonnier L.M., Apparailly F., van der Voort E.I., Jorgensen C., Huizinga T.W., Toes R.E. Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J. Immunol. 2007, 179:1506-1515.
5. Popov I., Li M., Zheng X., San H., Zhang X., Ichim T., Suzuki M., Feng B., Vladau C., Zhong R., Garcia B., Strejan G., Inman R., Min W.P. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res. Ther. 2006, 8:R141.
6. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann. N. Y. Acad. Sci. 2003, 987:258-261.
7. Phillips B.E., Giannoukakis N., Trucco M. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus. Pediatr. Endocrinol. Rev. 2008, 5:873-879.
8. Chorny A., Gonzalez-Rey E., Fernandez-Martin A., Pozo D., Ganea D., Delgado M. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13562-13567.
9. Giannoukakis N., Phillips B., Finegold D., Harnaha J., Trucco M. Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011, 9:2026-2036.
10. Zahorchak A.F., Kean L.S., Tokita D., Turnquist H.R., Abe M., Finke J., Hamby K., Rigby M.R., Larsen C.P., Thomson A.W. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation 2007, 84:196-206.
11. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
12. Boks M.A., Zwaginga J.J., van Ham S.M., B.A.ten An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells. Scand. J. Immunol. 2010, 72:158-168.
13. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997, 159:4772-4780.
14. Sato K., Yamashita N., Baba M., Matsuyama T. Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003, 101:3581-3589.
15. McBride J.M., Jung T., de Vries J.E., Aversa G. IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell. Immunol. 2002, 215:162-172.
16. Gregori S., Tomasoni D., Pacciani V., Scirpoli M., Battaglia M., Magnani C.F., Hauben E., Roncarolo M.G. Differentiation of type 1 T regulatory (Tr1) cells by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 2010, 116:935-944.
17. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., Di Carlo V. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 1999, 162:6473-6481.
18. Xia C.Q., Peng R., Beato F., Clare-Salzler M.J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 2005, 62:45-54.
19. + T-cell populations. Am. J. Transplant. 2006, 6:2580-2591.
20. Unger W.W., Laban S., Kleijwegt F.S., van der Slik A.R., Roep B.O. Induction of Treg by monocyte-derived DC modulated by vitamin D(3) or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 2009, 39:3147-3159.
21. Chamorro S., Garcia-Vallejo J.J., Unger W.W.J., Fernandes R.J., Bruijns S.C.M., Laban S., Roep B.O., 't Hart B.A., van Kooyk Y. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J. Immunol. 2009, 183:2984-2994.
22. Naranjo-Gomez M., Raich-Regue D., Onate C., Grau-Lopez L., Ramo-Tello C., Pujol-Borrell R., Martinez-Caceres E., Borras F.E. Comparative study of clinical grade human tolerogenic dendritic cells. J. Transl. Med. 2011, 9:89.
23. Penna G., Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164:2405-2411.
24. Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E., Allavena P., Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000, 164:4443-4451.
25. + T regulatory cells and promote organ transplant tolerance. J. Immunol. 2007, 178:7018-7031.
26. Fedoric B., Krishnan R. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction. Immunol. Lett. 2008, 120:49-56.
27. Monti P., Mercalli A., Leone B.E., Valerio D.C., Allavena P., Piemonti L. Rapamycin impairs antigen uptake of human dendritic cells. Transplantation 2003, 75:137-145.
28. Li G., Abediankenari S., Kim Y.J., Campbell T.B., Ito S., Graham-Evans B., Cooper S., Broxmeyer H.E. TGF-[beta] combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors. Blood 2007, 110:2872-2879.
29. Fogel-Petrovic M., Long J.A., Misso N.L., Foster P.S., Bhoola K.D., Thompson P.J. Physiological concentrations of transforming growth factor [beta]1 selectively inhibit human dendritic cell function. Int. Immunopharmacol. 2007, 7:1924-1933.
30. Xiao B.G., Zhu W.H., Lu C.Z. The presence of GM-CSF and IL-4 interferes with effect of TGF-[beta]1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis. Cell. Immunol. 2007, 249:30-36.
31. + T cells. J. Immunol. 2010, 184:1765-1775.
32. Forster R., Davalos-Misslitz A.C., Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 2008, 8:362-371.
33. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996, 62:659-665.
34. Rastellini C., Lu L., Ricordi C., Starzl T.E., Rao A.S., Thomson A.W. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995, 60:1366-1370.
35. Farquhar C.A., Paterson A.M., Cobbold S.P., Garcia R.H., Fairchild P.J., Yates S.F., Adams E., Saunders N.J., Waldmann H., Nolan K.F. Tolerogenicity is not an absolute property of a dendritic cell. Eur. J. Immunol. 2010, 40:1728-1737.
36. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003, 21:685-711.
37. Thomson A.W., Robbins P.D. Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann. Rheum. Dis. 2008, 67:90-96.
38. Jonuleit H., Schmitt E., Steinbrink K., Enk A.H. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001, 22:394-400.
39. + regulatory T cells including suppressors of alloreactivity. Immunol. Rev. 2006, 212:314-329.
40. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 2007, 7:585-598.
41. Vignali D.A.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
42. + T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
43. ten Brinke A., Karsten M.L., Dieker M.C., Zwaginga J.J., Vrielink H., Marieke van Ham S. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation. Immunobiology 2006, 211:633-640.
44. ten Brinke A., Karsten M.L., Dieker M.C., Zwaginga J.J., van Ham S.M. The clinical grade maturation cocktail monophosphoryl lipid A plus IFN[gamma] generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization. Vaccine 2007, 25:7145-7152.
45. Anderson A.E., Swan D.J., Sayers B.L., Harry R.A., Patterson A.M., von Delwig A., Robinson J.H., Isaacs J.D., Hilkens C.M.U. LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J. Leukoc. Biol. 2009, 85:243-250.
46. Ulrich J.T., Myers K.R. Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. Pharm. Biotechnol. 1995, 6:495-524.
47. Vlad G., Chang C.C., Colovai A.I., Berloco P., Cortesini R., Suciu-Foca N. Immunoglobulin-like transcript 3: a crucial regulator of dendritic cell function. Hum. Immunol. 2009, 70:340-344.
48. Chui C.S., Li D. Role of immunolglobulin-like transcript family receptors and their ligands in suppressor T-cell-induced dendritic cell tolerization. Hum. Immunol. 2009, 70:686-691.
49. Fife B.T., Pauken K.E., Eagar T.N., Obu T., Wu J., Tang Q., Azuma M., Krummel M.F., Bluestone J.A. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 2009, 10:1185-1192.
50. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., Sharpe A.H. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 2009, 206:3015-3029.
51. Keir M.E., Butte M.J., Freeman G.J., Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008, 26:677-704.
52. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997, 27:3135-3142.
53. Sordi V., Bianchi G., Buracchi C., Mercalli A., Marchesi F., D'Amico G., Yang C.H., Luini W., Vecchi A., Mantovani A., Allavena P., Piemonti L. Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: selective upregulation by rapamycin. Transplantation 2006, 82:826-834.
54. Morelli A.E., Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 2007, 7:610-621.
55. Kalinski P., Vieira P.L., Schuitemaker J.H.N., de Jong E.C., Kapsenberg M.L. Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001, 97:3466-3469.
56. Beinhauer B.G., McBride J.M., Graf P., Pursch E., Bongers M., Rogy M., Korthauer U., de Vries J.E., Aversa G., Jung T. Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur. J. Immunol. 2004, 34:74-80.
57. Manavalan J.S., Rossi P.C., Vlad G., Piazza F., Yarilina A., Cortesini R., Mancini D., Suciu-Foca N. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 2003, 11:245-258.
58. Voigtlander C., Rossner S., Cierpka E., Theiner G., Wiethe C., Menges M., Schuler G., Lutz M.B. Dendritic cells matured with TNF can be further activated in vitro and after subcutaneous injection in vivo which converts their tolerogenicity into immunogenicity. J. Immunother. 2006, 29:407-415.
59. + Tr cells. Blood 2005, 105:1162-1169.
60. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001, 193:233-238.
61. + anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002, 99:2468-2476.
62. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006, 212:28-50.
63. Taner T., Hackstein H., Wang Z., Morelli A.E., Thomson A.W. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am. J. Transplant. 2005, 5:228-236.
64. Hackstein H., Taner T., Zahorchak A.F., Morelli A.E., Logar A.J., Gessner A., Thomson A.W. Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 2003, 101:4457-4463.